Tenon Medical, Inc. Warrant

NASDAQ:TNONW USA Medical Devices
Market Cap
$101.57
Market Cap Rank
#50069 Global
#15291 in USA
Share Price
$0.01
Change (1 day)
+16.13%
52-Week Range
$0.01 - $0.03
All Time High
$0.12
About

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sa… Read more

Tenon Medical, Inc. Warrant (TNONW) - Net Assets

Latest net assets as of June 2024: $832.00K USD

Based on the latest financial reports, Tenon Medical, Inc. Warrant (TNONW) has net assets worth $832.00K USD as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.01 Million) and total liabilities ($5.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $832.00K
% of Total Assets 13.85%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Tenon Medical, Inc. Warrant - Net Assets Trend (2020–2022)

This chart illustrates how Tenon Medical, Inc. Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Tenon Medical, Inc. Warrant (2020–2022)

The table below shows the annual net assets of Tenon Medical, Inc. Warrant from 2020 to 2022.

Year Net Assets Change
2022-12-31 $6.25 Million +130.42%
2021-12-31 $-20.55 Million -658.76%
2020-12-31 $-2.71 Million --

Equity Component Analysis

This analysis shows how different components contribute to Tenon Medical, Inc. Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3500582900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2022)

Component Amount Percentage
Other Components $45.74 Million 731.67%
Total Equity $6.25 Million 100.00%

Tenon Medical, Inc. Warrant Competitors by Market Cap

The table below lists competitors of Tenon Medical, Inc. Warrant ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tenon Medical, Inc. Warrant's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from -20,552,000 to 6,252,000, a change of 26,804,000.
  • Net loss of 18,917,000 reduced equity.
  • New share issuances of 14,139,000 increased equity.
  • Other factors increased equity by 31,582,000.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income $-18.92 Million -302.58%
Share Issuances $14.14 Million +226.15%
Other Changes $31.58 Million +505.15%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Tenon Medical, Inc. Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 $-3.66 $0.01 x
2021-12-31 $-18.29 $0.01 x
2022-12-31 $5.56 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tenon Medical, Inc. Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -302.58%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2737.63%
  • • Asset Turnover: 0.06x
  • • Equity Multiplier: 1.77x
  • Recent ROE (-302.58%) is below the historical average (-100.86%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 0.00% -1335.41% 0.11x 0.00x $-143.61K
2021 0.00% -4405.00% 0.02x 0.00x $-4.99 Million
2022 -302.58% -2737.63% 0.06x 1.77x $-19.54 Million

Industry Comparison

This section compares Tenon Medical, Inc. Warrant's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $539,803,485
  • Average return on equity (ROE) among peers: -52.41%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Tenon Medical, Inc. Warrant (TNONW) $832.00K 0.00% 6.22x $99.76
Advanced Biomedical Technologies Inc (ABMT) $-7.40 Million 0.00% 0.00x $14.18K
Abbott Laboratories (ABT) $3.67 Billion 38.07% 1.09x $190.05 Billion
Acarix AB (publ) (ACIXF) $1.44 Million -102.09% 0.28x $26.42 Million
Adagio Medical Holdings, Inc Common Stock (ADGM) $-13.54K 0.00% 0.00x $4.05 Million
Adm Tronics Unltd (ADMT) $2.76 Million -21.69% 0.89x $3.17 Million
Aethlon Medical Inc (AEMD) $9.28 Million -68.70% 0.12x $2.76 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $732.88K
Adapthealth Corp (AHCO) $1.58 Billion 5.73% 1.84x $911.62 Million
Allied Healthcare Products Inc. (AHPIQ) $11.89 Million -17.74% 0.30x $726.24
20/20 Biolabs, Inc. Common Stock (AIDX) $456.18K -277.12% 2.12x $10.62 Million